Navigation Links
India's Non-Small-Cell Lung Cancer Drug Market Will Almost Double by 2013
Date:5/13/2009

Western Branded Drug Sales Will Command 54 percent of the Market by 2013, According to a New Report from Decision Resources

WALTHAM, Mass., May 13 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the non-small-cell lung cancer drug market in India will almost double by 2013, growing from $27.7 million in 2008 to $52.1 million in 2013. This growth will be fueled by an increased uptake of antimetabolites and targeted therapies. In fact, the epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) inhibitor drug classes will dominate the market throughout the forecast period with a combined market share of 55 percent by 2013.

The new Emerging Markets report entitled Non-Small-Cell Lung Cancer in India also finds that Western-branded drug sales in India's non-small-cell lung cancer market will command 54 percent by 2013. Even though Western-branded small-molecule agents are facing fierce competition from domestic products, including gefitinib (in the U.S. known as AstraZeneca's Iressa) and erlotinib (in the U.S. known as Genentech's Tarceva), future opportunities for Western companies will depend heavily on their pricing strategies and their patent protection in India. Moreover, monoclonal antibodies will surge and won't be copied successfully during the report's 2008 - 2013 forecast period.

"Opportunity for Western companies penetrating or wanting to penetrate India's non-small-cell lung cancer (NSCLC) drug market lies in forming alliances with Indian companies in order to negotiate the complex regulatory process of getting new NSCLC therapies to market," stated Manashi Sherawat, Ph.D., analyst at Decision Resources. "Opportunity also lies in raising awareness of this form of cancer in
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Chinese Non-Small-Cell Lung Cancer Drug Market Will More Than Double by 2013
2. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
3. Survival differences by race most apparent in advanced stages of breast cancer
4. MRI finds breast cancer before it becomes dangerous
5. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
6. Pathway links inflammation, angiogenesis and breast cancer
7. Radiologists encouraged to look beyond cancer for clinically unseen diseases
8. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
9. Immune deficiency linked to a type of eye cancer
10. Drop in breast cancer incidence linked to hormone use, not mammograms
11. Breast cancer prevention practices vary across Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... Recently, BellasDress has launched ... wedding dresses. BellasDress has chosen their best-selling lace wedding ... for the holiday season. , Now, BellasDress.com features ... gowns here at discount prices. The business hopes everyone ... website. , “All our elegant products are ...
(Date:12/25/2014)... 25, 2014 When head lice hits a ... a frenzy to get rid of it while keeping it ... Coral Gables now have the solution right in their neighborhood: ... location, Lice Troopers provides full spectrum head lice screening and ... area, including Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest ...
(Date:12/25/2014)... News) -- The risk of burns from fires and ... to be extra cautious, an expert says. "Between ... increase in patients coming in with burns," said Dr. ... Firefighters Burn Center of Stony Brook University Hospital in ... joy, but if not careful, could quickly turn tragic," ...
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... could be closing in on a "fountain of youth" drug ... health of older adults, a new study suggests. Seniors ... a drug that targets a genetic signaling pathway linked to ... report. The experimental medication, a version of ...
(Date:12/25/2014)... “ SmileStix ” was featured on NewsWatch as ... coolest mobile applications on the iOS, Android, and Windows markets. ... conducted the app review and shared with viewers how this ... The old saying goes, “A picture says a thousand words.” ... describe a single image, because each picture holds a unique ...
Breaking Medicine News(10 mins):Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2
... deliveries a possible cause, study suggests, , , WEDNESDAY, Jan. ... of women giving birth experience severe complications, a new ... between 1998 and 2005. , Problems such as blood ... need for blood transfusions rose from 0.64 percent in ...
... 2009) The American Gastroenterological Association (AGA) Institute journal, ... journal with the most impact on the field of ... Science Indicators data by Thompson Reuters. This impact was ... any clinical medical journal. The current citation record for ...
... study appearing in The Prostate has found that ... as MV-CEA, may prove to be an effective treatment for ... type of treatment, called virotherapy, can effectively infect, replicate in ... a leading cause death among males in the western world. ...
... AUSTIN, Texas, Jan. 21 Alliance Tech ... measurement utilizing RFID, announced today that Carestream ... measurement technologies to identify additional lead opportunities ... North America (RSNA) conference held in Chicago ...
... and Germany pledge critically needed funds and urge ... crippling childhood diseaseSAN DIEGO, Jan. 21 Rotary ... the British and German governments today committed more ... polio, a crippling and sometimes fatal disease that ...
... and services, announced that Maggie O,Hara, IVANS group vice president of ... finalist in the fifth annual Women of Innovation awards program hosted ... ... (Vocus) January 21, 2009 -- IVANS, Inc. , a leading ...
Cached Medicine News:Health News:Severe Obstetric Complications on the Increase 2Health News:Severe Obstetric Complications on the Increase 3Health News:Clinical Gastroenterology and Hepatology most influential journal in field of clinical medicine 2Health News:Measles virus may be effective prostate cancer treatment 2Health News:Alliance Tech's RFID Technology Enhances Carestream Health's Capability to Connect with Key Prospects at RSNA 2Health News:Alliance Tech's RFID Technology Enhances Carestream Health's Capability to Connect with Key Prospects at RSNA 3Health News:Global Health Community Commits Over $630 Million in Aggressive Push for Polio Eradication 2Health News:Global Health Community Commits Over $630 Million in Aggressive Push for Polio Eradication 3Health News:Global Health Community Commits Over $630 Million in Aggressive Push for Polio Eradication 4Health News:Maggie O'Hara Named as a Finalist in Connecticut Technology Council's Women of Innovation Awards Program 2Health News:Maggie O'Hara Named as a Finalist in Connecticut Technology Council's Women of Innovation Awards Program 3
(Date:12/24/2014)... 2014  Lockton Dunning Benefits, the ... the addition of Vice President Kim Foerster ... Pharmacy Consulting team, Excelsior Solutions. ... to the position.  Most recently, she worked as ... Specialty Pharmacy, where she has held various managerial ...
(Date:12/24/2014)... 2014  Medical Science Liaisons play a large role ... the medical device industry and key stakeholders, the role ... years as the device industry relies on them to ... by benchmarking firm, Best Practices, LLC, one area where ... is by harnessing new technology to enable education. Online ...
(Date:12/22/2014)... MEMPHIS, Tenn. , Dec. 22, 2014   ... only automated, no-touch UV disinfection robot, announced today that ... GSA Schedule contract through November 2019.   ... to rapidly engage all levels of government purchasers, including ... facilities, as well as Homeland Security contacts purchasing solutions ...
Breaking Medicine Technology:Kim Foerster Joins Lockton Companies 2Role of Medical Science Liaisons Evolving in Medical Device Sector 2TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2
... A of Trial Assessing Regimen of ... TUSTIN, Calif., Oct. 7 Peregrine,Pharmaceuticals, Inc. (Nasdaq: ... for the treatment of cancer and,hepatitis C virus (HCV) ... first stage of a Phase II trial of bavituximab ...
... TOKYO and CHIPPENHAM, England, October 7 ,Sosei ... and Vectura,Group plc ("Vectura"; LSE: VEC), announce ... efficacy, safety and tolerability of NVA237 presented ... Society (ERS) in Berlin,Germany. The new data ...
Cached Medicine Technology:Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5
... The SR™ Hand Implant System utilizes ... and knee joint replacements. The SR™ ... available in other prostheses including minimal bone ... eroded cartilaginous articular surfaces, retention and/or repositioning ...
The NeurOptics Pupillometer is a portable instrument used to measure pupils to screen candidates for refractive procedures and other ophthalmic applications....
... system features an advanced design that accommodates ... system gives surgeons the flexibility to easily ... Flexibility is built-in to every aspect of ... innovative Secure-TwistTM anti-migration system to the screw ...
... The SC-Acufix anterior cervical plate system is ... patented, integrated swivel, which provides for consistent, ... prevents bone screw disengagement or backout. This ... secondary locking screw. Simply implant your screws ...
Medicine Products: